Search -

Displaying 101 - 120 of 667

Sort: Relevancy | Date

Presentation TVT 2019

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Technology Description

Presenter: Jian Ye

June 13, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Large-Hole Transfemoral Closure III: The PerQseal Device

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

When Transfemoral Access Is Problematic — Facilitation With Intravascular Balloon Lithotripsy

Presenter: David Wood

June 13, 2019

Presentation TVT 2019

When Transfemoral Access Isn’t Available — A Systematic Approach to Alternative Access for TAVR

Presenter: Amir Kaki

June 13, 2019

Presentation TVT 2019

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Presenter: Michael Rinaldi

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Daily News

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

L.A. McKeown

May 30, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

Advertisement

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Illustrative Cases

Technology Description

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

2 Illustrative Cases – A Case-Based Discussion

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Large-Hole Transfemoral Closure III: The PerQseal Device

When Transfemoral Access Is Problematic — Facilitation With Intravascular Balloon Lithotripsy

When Transfemoral Access Isn’t Available — A Systematic Approach to Alternative Access for TAVR

Transfemoral Access for TAVR Made 'Simple' — Tips and Tricks to Optimize Outcomes

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

TAVR Operators: Can One Do It All or Are Two Still Justified?

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content